Genitourinary syndrome of menopause affects the majority of postmenopausal women, yet it remains underdiagnosed and undertreated despite causing significant discomfort and affecting quality of life.

Understanding Treatment Goals for This Common Condition

When menopause arrives, many women experience changes that extend far beyond hot flashes and mood swings. Genitourinary syndrome of menopause, or GSM, is a collection of symptoms affecting the vagina, vulva, and lower urinary tract that can significantly impact daily life. The main goal of treating this condition is to relieve uncomfortable symptoms and restore quality of life, allowing women to remain sexually active, maintain bladder control, and avoid recurrent infections. Treatment strategies depend on how severe the symptoms are, which specific problems are most bothersome, and each woman’s personal health history.^[1]

This is a chronic and progressive condition, meaning that without treatment, symptoms typically persist and often worsen over time. Unlike hot flashes that may fade on their own, GSM symptoms do not improve spontaneously. This makes early recognition and appropriate treatment especially important. Medical societies have established standard treatment approaches, and researchers continue to explore new therapies through clinical trials to help women find relief from these troubling symptoms.^[2]

The approach to treating GSM has evolved significantly in recent years. Healthcare providers now recognize that this is not simply a cosmetic or minor problem, but rather a medical condition that deserves proper attention and care. Treatment decisions take into account whether a woman is sexually active, whether urinary symptoms are the primary concern, and whether she has any medical conditions that might affect which treatments are safe for her to use.^[8]

Standard Treatment Approaches: From Simple to Comprehensive

The first line of treatment for GSM typically involves non-hormonal options that many women can try on their own. These approaches focus on maintaining moisture in the vaginal tissues and reducing discomfort during sexual activity. Vaginal lubricants are products applied just before sexual activity to reduce friction and discomfort. Water-based options are generally recommended because they are less likely to cause irritation and are safe to use with condoms. Examples include products like Astroglide, K-Y Jelly, and Sliquid. These lubricants provide immediate but temporary relief during intimacy.^[1]

Vaginal moisturizers work differently from lubricants. These products are designed to be used regularly, typically every few days, regardless of sexual activity. They help restore some moisture to the vaginal area and their effects last longer than lubricants. Common over-the-counter vaginal moisturizers include Replens, Refresh, Good Clean Love, and Luvena. These products can be helpful for women experiencing mild to moderate vaginal dryness and irritation.^[1]

Lifestyle modifications also play an important role in managing GSM symptoms. Maintaining regular sexual activity, either with a partner or through self-stimulation, can help preserve vaginal health by promoting blood flow to the tissues. Smoking cessation is strongly recommended, as smoking can worsen symptoms by reducing blood flow to vaginal tissues. Women are also advised to avoid using personal hygiene products in the vulvovaginal area, as these can cause irritation and disrupt the natural balance of the vagina. Simple soap and water are usually sufficient for cleaning the external genital area.^[1]

For women whose symptoms do not improve with non-hormonal options, vaginal estrogen therapy is widely considered the gold standard treatment. This approach is generally the most effective treatment for GSM. Vaginal estrogen is available in several forms: creams, tablets, and rings. Each form delivers a small amount of estrogen directly to the vaginal tissues, where it is most needed. The cream is applied with a special applicator, tablets are inserted into the vagina, and the ring is a flexible device that is placed in the vagina and slowly releases estrogen over several months.^[1]

The way vaginal estrogen works is by restoring health to the vaginal and urinary tissues. Estrogen is a type of hormone that promotes and maintains female traits in the body. When applied locally to the vagina, it thickens the skin of the vaginal canal, increases natural lubrication, and restores the normal acidity (pH) of the vagina. This creates an environment that is less susceptible to infection and less prone to irritation. Multiple studies have shown that vaginal estrogen can reduce the risk of urinary tract infections, which are common in women with GSM.^[1]

The duration of treatment with vaginal estrogen varies depending on individual needs. Because GSM is a chronic condition resulting from permanently reduced estrogen levels after menopause, many women need to continue treatment long-term to maintain symptom relief. However, the dosage and frequency may be adjusted over time. Doctors typically start with more frequent applications and then reduce to a maintenance schedule once symptoms improve.^[8]

The most common side effects of vaginal estrogen are mild and local. Some women may experience slight vaginal bleeding or spotting, especially when first starting treatment. Breast tenderness can occasionally occur. Vaginal irritation or discharge is possible but uncommon. To minimize potential exposure to a sexual partner, it is generally recommended to wait about 12 hours after inserting vaginal estrogen before having sex, although the risk to a partner is not considered significant.^[1]

Another treatment option that has been studied is dehydroepiandrosterone (DHEA), marketed under the brand name Intrarosa. This is a hormone that the body can convert into both estrogen and testosterone. When inserted into the vagina as a suppository, DHEA can help improve vaginal tissue health and reduce pain during intercourse. This option may be suitable for women who prefer an alternative to traditional estrogen therapy.^[8]

Selective estrogen receptor modulators, or SERMs, represent another class of medications. Ospemifene (brand name Osphena) is an oral medication that acts like estrogen in some tissues while blocking estrogen effects in others. It is taken as a daily pill and can help improve vaginal tissue health and reduce pain during sexual activity. This option may appeal to women who prefer an oral medication rather than a vaginal treatment. However, because it is taken by mouth and absorbed systemically, it may carry different risks than vaginal estrogen and requires careful discussion with a healthcare provider.^[8]

For women who need quick relief from painful intercourse, mucosal lidocaine can be helpful. Lidocaine is a numbing medication that can be applied to the vaginal opening before sexual activity to reduce discomfort. This is typically used as a temporary measure while other treatments take effect, as it addresses the pain symptom but not the underlying tissue changes.^[1]

Some women may also benefit from hyaluronic acid preparations. Hyaluronic acid is a substance naturally found in the body that helps retain moisture. When applied vaginally, it can help improve tissue hydration and may promote healing. This is considered a non-hormonal option that can be used alone or in combination with other treatments.^[8]

Innovative Treatments Being Studied in Clinical Trials

As researchers work to find better ways to help women with GSM, several innovative approaches are being tested in clinical trials. One area of active investigation involves energy-based devices, particularly laser treatments. These procedures use controlled energy to stimulate the vaginal tissues, with the goal of promoting collagen production and tissue regeneration. Two main types of laser have been studied: carbon dioxide (CO2) lasers and erbium:YAG lasers.^[8]

The theory behind laser treatment is that by creating controlled micro-injuries to the vaginal tissue, the body’s natural healing response is triggered, leading to increased collagen production, improved blood flow, and thicker, healthier tissue. The procedure is typically performed in a doctor’s office and takes only a few minutes. Multiple treatment sessions are usually required, often spaced several weeks apart, followed by occasional maintenance treatments.^[8]

However, the evidence for laser therapy in GSM remains mixed and controversial. Some early studies showed promising results, with women reporting improvements in vaginal dryness, pain during sex, and sexual function. These improvements were often noted within weeks of treatment. However, more rigorous research has been less encouraging. A major study published in the Journal of the American Medical Association (JAMA) found no significant improvement in vaginal symptoms one year after laser treatment when compared with a placebo procedure. This means that the laser treatment was no better than a fake treatment in the long term.^[1]

The benefits of laser therapy, when they do occur, may be short-lived. Studies suggest that any positive effects typically last only a few months rather than providing lasting relief. This raises questions about the cost-effectiveness of repeated treatments. Additionally, potential adverse events associated with laser use have been reported, including vaginal pain, vaginal bleeding, and urinary tract infections. These complications, while not common, are important considerations.^[1]

Clinical trials continue to investigate ways to optimize laser protocols, identify which women might benefit most, and determine the ideal frequency of treatments. Researchers are also studying whether combining laser therapy with other treatments might improve outcomes. These studies are being conducted at medical centers in Europe, the United States, and other regions. Women interested in laser therapy may be able to participate in these ongoing trials, which would provide access to the treatment while contributing to our understanding of its effectiveness.^[8]

Another area of clinical investigation involves refining the use of existing hormonal therapies. Researchers are studying different doses and formulations of vaginal estrogen to find the most effective options with the fewest side effects. Some trials are examining ultra-low-dose vaginal estrogen to determine if even smaller amounts of hormone can provide symptom relief while further minimizing any potential systemic absorption. These studies typically fall into Phase II trials, which focus on determining the optimal dose and assessing effectiveness in treating specific symptoms.^[8]

Combination therapies are also being explored in clinical research. Some studies are investigating whether using vaginal estrogen together with vaginal DHEA provides better relief than either treatment alone. The rationale is that DHEA can be converted into both estrogen and testosterone locally in the vaginal tissues, potentially addressing symptoms from multiple angles. These trials aim to compare symptom improvement, quality of life measures, and side effects between the combination and single-agent treatments.^[8]

New selective estrogen receptor modulators are also being developed and tested. These medications are designed to activate estrogen receptors in the vaginal and urinary tissues while minimizing effects in other parts of the body. Phase III trials for some of these compounds compare them with existing treatments to determine if they offer advantages in terms of effectiveness, safety, or ease of use. Such trials typically involve hundreds of participants and last for months to years, providing comprehensive safety and effectiveness data.^[8]

Researchers are also investigating the role of the vaginal microbiome in GSM. The microbiome refers to the community of bacteria and other microorganisms that naturally live in the vagina. A healthy vaginal microbiome is dominated by beneficial Lactobacillus bacteria, which help maintain proper acidity and protect against infections. Some clinical trials are testing whether specific probiotic supplements containing Lactobacillus strains can help restore a healthy vaginal environment and reduce GSM symptoms. These trials are examining whether probiotics can be used alone for mild symptoms or as an add-on to standard treatments.^[8]

Clinical trials for GSM treatments are conducted at various locations worldwide, including major medical centers in the United States, Canada, Europe, and other regions. Eligibility for participation typically depends on factors such as age, menopausal status, severity of symptoms, and medical history. Women with certain health conditions, such as active breast cancer or uncontrolled bleeding disorders, may not be eligible for some trials. Those interested in participating in clinical research can ask their healthcare provider about available studies or search clinical trial registries online.^[8]

Most common treatment methods

• Non-hormonal vaginal treatments
  • Vaginal lubricants like Astroglide, K-Y Jelly, and Sliquid for use during sexual activity
  • Vaginal moisturizers such as Replens, Refresh, Good Clean Love, and Luvena for regular use every few days
  • Mucosal lidocaine for temporary pain relief during intercourse
  • Hyaluronic acid preparations to improve tissue hydration
• Hormonal therapies
  • Vaginal estrogen in cream, tablet, or ring form applied directly to vaginal tissues
  • Dehydroepiandrosterone (DHEA) vaginal suppositories that convert to estrogen and testosterone locally
  • Selective estrogen receptor modulators like ospemifene taken as oral medication
• Lifestyle modifications
  • Maintaining regular sexual activity to promote blood flow
  • Smoking cessation to improve tissue health
  • Avoiding irritating personal hygiene products in the vulvovaginal area
• Investigational treatments
  • Energy-based devices including CO2 laser and erbium:YAG laser for tissue regeneration
  • Probiotic supplements containing Lactobacillus strains to restore vaginal microbiome
  • Combination therapies using multiple approaches together